Experiences of young mothers with the uptake of Sulfadoxine-Pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a cross-sectional study in the Lake endemic region, Kenya

BackgroundA substantial proportion of the world population is affected by malaria with 241 million malaria cases reported globally. Intermittent Preventive Treatment in pregnancy (IPTp) with Sulfadoxine-Pyrimethamine (SP) is an effective chemotherapy but its utilisation has not been optimised. Few s...

Full description

Bibliographic Details
Published in:	Frontiers in Global Women's Health
Main Authors:	Dennis Juma Matanda, Tchaiwe Zulu, George Odwe, Oscar Okoth, Zoe Nakuya
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-03-01
Subjects:	malaria in pregnancy intermittent preventive treatment Sulfadoxine-Pyrimethamine young mothers Kenya
Online Access:	https://www.frontiersin.org/articles/10.3389/fgwh.2024.1294893/full

Similar Items

Women’s empowerment and uptake of sulfadoxine–pyrimethamine for intermittent preventive treatment of malaria during pregnancy: results from a cross-sectional baseline survey in the Lake endemic region, Kenya
by: George Odwe, et al.
Published: (2023-08-01)

Sulfadoxine/Pyrimethamine Intermittent Preventive Treatment for Malaria during Pregnancy
by: Philippe Deloron, et al.
Published: (2010-11-01)

Superiority trial of intermittent treatment with dihydroartemisinin–piperaquine versus sulfadoxine–pyrimethamine for the prevention of malaria during pregnancy
by: Roland Nnaemeka Okoro, et al.
Published: (2023-01-01)

The Comparative Effects of Antenatal Azithromycin and Sulfadoxine-pyrimethamine on Maternal Malaria during Pregnancy
by: Ganiyu Olanipekun Ahmed, et al.
Published: (2024-10-01)

Individual and community-level correlates of optimal doses of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy in Tanzania: a multilevel analysis of the 2022 national survey
by: Elihuruma Eliufoo Stephano, et al.
Published: (2025-07-01)

Effectiveness of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine: An in silico pharmacological model
by: Mila Nu Nu Htay, et al.
Published: (2020-01-01)

A roadmap for understanding sulfadoxine-pyrimethamine in malaria chemoprevention
by: Thiery Masserey, et al.
Published: (2025-02-01)

Investigating the dynamics of Plasmodium falciparum gametocyte carriage in expectant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Kilifi, study protocol [version 2; peer review: 3 approved]
by: Isabella Oyier, et al.
Published: (2025-04-01)

Investigating the dynamics of Plasmodium falciparum gametocyte carriage in expectant women under intermittent preventive treatment with sulfadoxine-pyrimethamine in Kilifi, study protocol [version 1; peer review: 2 approved]
by: Isabella Oyier, et al.
Published: (2025-03-01)

Factors influencing low coverage of optimal dose of intermittent preventive treatment with sulfadoxine-pyrimethamine among pregnant women in Farafangana, Madagascar, 2024
by: Botovola Miraimila, et al.
Published: (2025-10-01)

Sex of household head and trends in uptake of sulfadoxine-pyrimethamine intermittent preventive treatment for malaria during pregnancy: insights from secondary data in sub-Saharan Africa
by: Benjamin Kobina Kwansa, et al.
Published: (2025-03-01)

Intermittent preventive treatment with sulfadoxine-pyrimethamine does not modify plasma cytokines and chemokines or intracellular cytokine responses to <it>Plasmodium falciparum </it>in Mozambican Children
by: Quelhas Diana, et al.
Published: (2012-01-01)

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V
by: Mary C. Oguike, et al.
Published: (2016-12-01)

Determinants of uptake of intermittent preventive treatment during pregnancy: a review
by: Elaine Roman, et al.
Published: (2019-11-01)

Evidence on sulfadoxine-pyrimethamine resistance molecular markers from India: interpret with caution
by: Nimita Deora, et al.
Published: (2024-07-01)

Chloroquine and Sulfadoxine–Pyrimethamine Resistance in Sub-Saharan Africa—A Review
by: Alexandra T. Roux, et al.
Published: (2021-06-01)

Profile of molecular markers of Sulfadoxine-Pyrimethamine-resistant Plasmodium falciparum in individuals living in southern area of Brazzaville, Republic of Congo
by: Jean Claude Djontu, et al.
Published: (2024-12-01)

Surveillance for sulfadoxine-pyrimethamine resistant malaria parasites in the Lake and Southern Zones, Tanzania, using pooling and next-generation sequencing
by: Jeremiah M. Ngondi, et al.
Published: (2017-06-01)

Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru
by: Alan J. Magill, et al.
Published: (2004-06-01)

Dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a systematic review and individual participant data meta-analysisResearch in context
by: Michelle E. Roh, et al.
Published: (2025-05-01)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
by: Sokhina C.S, et al.
Published: (2001-09-01)

Molecular identification of sulfadoxine-pyrimethamine resistance in malaria infected women who received intermittent preventive treatment in the Democratic Republic of Congo
by: Emrah Ruh, et al.
Published: (2018-01-01)

Projected uptake of sulfadoxine–pyrimethamine for perennial malaria chemoprevention in children under 2 years of age in nine sub-Saharan African countries: an epidemiologically-based 5-year forecast analysis
by: Céline Audibert, et al.
Published: (2025-04-01)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
by: Basco Leonardo K., et al.
Published: (2002-01-01)

Stable high frequencies of sulfadoxine–pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine–pyrimethamine in Ujjain, Madhya Pradesh, India
by: Ashish Pathak, et al.
Published: (2020-08-01)

Disparate co-evolution and prevalence of sulfadoxine and pyrimethamine resistance alleles and haplotypes at dhfr and dhps genes across Africa
by: Nina F. D. White, et al.
Published: (2025-04-01)

A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Burkina Faso
by: Julie R. Gutman, et al.
Published: (2020-08-01)

Making the most of existing antimalarial medicines: a single dose cure with sulfadoxine–pyrimethamine plus artesunate–pyronaridine
by: Ghyslain Mombo-Ngoma, et al.
Published: (2025-09-01)

Effects of antifolates - co-trimoxazole and pyrimethamine-sulfadoxine - on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria
by: A Sowunmi, et al.
Published: (2005-07-01)

Audit of failure rate of sulfadoxine/pyrimetham combined with chloroquine to treat falciparum malaria at single fourteen-day follow-up
by: C.H. Vaughan Williams, et al.
Published: (2002-03-01)

Seasonal malaria chemoprevention in a context of high presumed sulfadoxine-pyrimethamine resistance: malaria morbidity and molecular drug resistance profiles in South Sudan
by: Irene Molina-de la Fuente, et al.
Published: (2023-11-01)

Knowledge, uptake and therapeutic effectiveness of sulfadoxine-pyrimethamine (IPTp-SP) among pregnant women attending the antenatal clinic at ayeduase Health Centre in Oforikrom Municipality in the Ashanti-region, Ghana
by: Daniel Ansong, et al.
Published: (2025-03-01)

Trends in Molecular Markers Associated with Resistance to Sulfadoxine-Pyrimethamine (SP) Among Plasmodium falciparum Isolates on Bioko Island, Equatorial Guinea: 2011–2017
by: Lin LY, et al.
Published: (2020-04-01)

Direct therapeutic effect of sulfadoxine-pyrimethamine on nutritional deficiency-induced enteric dysfunction in a human Intestine ChipResearch in context
by: Seongmin Kim, et al.
Published: (2024-01-01)

Comparative evaluation of the efficacy of chloroquine and sulphadoxine-pyrimethamine in the treatment of uncomplicated Malaria in children under five years in a Rural population of Enugu State
by: Henrietta U Okafor, et al.
Published: (2004-01-01)

Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
by: Moussa Lingani, et al.
Published: (2023-03-01)

High Frequency Mutations in pfdhfr and pfdhps of Plasmodium falciparum in Response to Sulfadoxine-Pyrimethamine: A Cross-Sectional Survey in Returning Chinese Migrants From Africa
by: He Yan, et al.
Published: (2021-09-01)

Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon [version 1; peer review: 2 approved, 1 approved with reservations]
by: Palmer M. Netongo, et al.
Published: (2024-06-01)

Intermittent screening using ultra-sensitive malaria rapid diagnostic test and treatment with pyronaridine-artesunate compared to standard preventive treatment with sulfadoxine-pyrimethamine for malaria prevention in pregnant women in Kinshasa, DRC
by: Japhet Kabalu Tshiongo, et al.
Published: (2025-02-01)

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlay Associated with Self-Medication of Sulfadoxine-Pyrimethamine Overdose in a Patient with HIV/AIDS Infection: A Case Report
by: Jalloh A, et al.
Published: (2025-05-01)